Federal Circuit Rules For Pfizer In Suit Over Norvasc Patent
The decision reverses an earlier ruling by a lower court in Newark, New Jersey.
The case has broad implications because Dr. Reddy's Laboratories Inc. tried to use a novel approach to make a generic version of Norvasc. The company used a different salt on its compound and claimed its drug...
To view the full article, register now.